Harbin Pingchuan Pharmaceutical

Harbin Pingchuan Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and manufacturing of Traditional Chinese Medicine (TCM) and chemical drugs. The company is widely recognized for its respiratory health portfolio, particularly its namesake Pingchuan series used for treating asthma and chronic bronchitis. Beyond respiratory care, the firm produces a variety of treatments for cardiovascular, cerebrovascular, and digestive system conditions. Operating out of Harbin, the company maintains GMP-certified production facilities and is listed on the National Equities Exchange and Quotations (NEEQ) in China.